Merck to Make New Investments in Singapore

Fierce Pharma (10/21/2011) Hollis, Liz Jones
Merck has signed an agreement to expand its presence in Singapore through new manufacturing, marketing and research investments. Under the agreement, Merck will invest more than $250 million over the next 10 years in site improvements at its manufacturing facilities in Tuas. It will also expand its biotech operations, adding capability to support new product launches.